Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762794
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairHumacyte, Inc.Not Yet RecruitingPhase 4
NCT07762794Not Yet Recruiting
Phase 4
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real Worl...Humacyte, Inc.
NCT07764250
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive ImpairmentShifa Tameer-e-Millat UniversityRecruitingNot Applicable
NCT07764250Recruiting
Not Applicable
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training i...Shifa Tameer-e-Millat Uni...
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763821
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Assiut UniversityNot Yet Recruiting
NCT07763821Not Yet Recruiting
—
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephrit...Assiut University
NCT07764055
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medical Technologies Co., Ltd.CompletedPhase 3
NCT07764055Completed
Phase 3
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medi...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07763405
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hospital of Nanchang UniversityNot Yet RecruitingPhase 4
NCT07763405Not Yet Recruiting
Phase 4
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hosp...
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07763444
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan UniversityCompletedNot Applicable
NCT07763444Completed
Not Applicable
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan Univers...
NCT07762625
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes MellitusCentral South UniversityNot Yet RecruitingNot Applicable
NCT07762625Not Yet Recruiting
Not Applicable
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestationa...Central South University
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07763392
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the LifespanIntraneuronRecruiting
NCT07763392Recruiting
—
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digit...Intraneuron
NCT07762092
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai LimitedNot Yet Recruiting
NCT07762092Not Yet Recruiting
—
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai Limited
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07763418
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal FunctionBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07763418Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participan...Bristol-Myers Squibb
NCT07763041
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, Maternal Attachment, and Infant Health in the NICUAnkara Medipol UniversityCompletedNot Applicable
NCT07763041Completed
Not Applicable
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, M...Ankara Medipol University
NCT07762586
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Rutgers, The State University of New JerseyRecruitingPhase 2
NCT07762586Recruiting
Phase 2
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NA...Rutgers, The State Univer...
NCT07762079
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion Program Among Patients With Mental Disorders - IRISFederation Regionale de Recherche en Psychiatrie et Sante Mentale OccitanieNot Yet RecruitingNot Applicable
NCT07762079Not Yet Recruiting
Not Applicable
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion P...Federation Regionale de R...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed4 (20%)
not_applicable7 (35%)
Not Specified7 (35%)
Phase 42 (10%)
Phase 22 (10%)
Phase 31 (5%)
Phase 11 (5%)